Subscribe
S8: #076: Fighting Cancer Through Early Detection of Biomarkers

Digital Health Today 360° with Dan Kendall

S8: #076: Fighting Cancer Through Early Detection of Biomarkers

Turning autoantibodies into an early-warning system against cancer
December 13, 2018
ADVERTISEMENT
EHRGo-THE FUTURE OF HEALTHCARE EDUCATION

S8: #076: Fighting Cancer Through Early Detection of Biomarkers

Turning autoantibodies into an early-warning system to beat cancer

In episode 74, we spoke about early detection of skin cancer with Erik de Heus, the CEO of SkinVision. In that episode we talked about a smartphone app that uses AI to determine the likelihood that a mole or mark on your skin could be malignant. That technology has reviewed millions of images and has helped detect cancer in tens of thousands of people around the world. It’s a great solution and it’s making a huge impact and it will continue to hold a vital place in our fight against skin cancer. But what about cancers below our skin’s surface? What tools do we have to detect and fight those cancers that we can’t see and that may be developing inside us?

Is there a way to detect those cancers even before they form a cluster of cells large enough to be detected through a biopsy or scan?

What if we could enlist the power of our own immune system to create a sort of early warning system that could alert us when cancerous cells are present.

Well, the good news is that such a technology does exist, and it’s being used to detect cancer 4 years earlier, or sometimes even more, for a wide range of solid tumor types. And all it requires is a simple blood test.

Our guest today is going to share how these technologies work, and how they are changing the way with think about the progression, detection and treatment of cancer.

With me to talk about it is Dr Adam M Hill, he is the CEO of a leading cancer detection company called Oncimmune. Adam is a both a Clinician and Mechanical Engineer, and has spent his career at the interface of industry, academia and health systems. Early in his career, he trained in surgery in the British Army and he helped a Formula One team become a developer of health technology.

Over the last 5 years, Adam has been an early stage investor in, and advisor to, a number of health technology startups. He is also a Visiting Professor in Global Health Innovation at Imperial College London. We cover a lot of ground in this episode and Adam and his team have developed a PDF that contains the key details we talk about in this program, so be sure to grab a copy of that as well.

Today’s Topics:

  • Brief introduction of Cancer in the biology and the foundation behind the technology
  • Biomarker antigens & novel approaches in detecting cancer cells and its impact in Cancer Care pathways and treatment
  • The possible changes in the paradigm of early Cancer detection, diagnosis, and post care treatment
  • How viable is this technology to the market and will it be in tandem with other technologies
  • What other recent breakthroughs in technology that relates to early Cancer detection

Links and Resources Mentioned:

This episode of Digital Health Today is made possible thanks to our sponsors. Thank you!

Learn more about your ad choices. Visit megaphone.fm/adchoices

ADVERTISEMENT
EHRGo-THE FUTURE OF HEALTHCARE EDUCATION

You may also like

The Best Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Medicines360 is constructing healthcare for women everywhere Dr. Jessica Grossman is the CEO of Medicines360, discusses increasing affordability and accessibility in women's health, equity in clinical studies, and demystifying birth control.